Immuneering
IMRX
IMRX
38 hedge funds and large institutions have $10.9M invested in Immuneering in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-21
Holders Change %
-35.59%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
18
Closed
27
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$1.12M |
| 2 |
T
Tidemark
San Diego,
California
|
$129K |
| 3 |
SM
Southport Management
Wilson,
Wyoming
|
$510K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$78.5K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
$159K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
Millennium Management
New York
|
$613K |
| 3 |
Goldman Sachs
New York
|
$0 |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
$473K |
| 5 |
BlackRock
New York
|
$793K |
